NDC 12634-416

Furosemide

Furosemide

Furosemide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Apotheca Inc.. The primary component is Furosemide.

Product ID12634-416_46675cd8-ad7f-40ae-e054-00144ff8d46c
NDC12634-416
Product TypeHuman Prescription Drug
Proprietary NameFurosemide
Generic NameFurosemide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-02-24
Marketing CategoryANDA / ANDA
Application NumberANDA077293
Labeler NameApotheca Inc.
Substance NameFUROSEMIDE
Active Ingredient Strength20 mg/1
Pharm ClassesIncreased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 12634-416-00

10 TABLET in 1 BOTTLE (12634-416-00)
Marketing Start Date2016-02-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 12634-416-82 [12634041682]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-42 [12634041642]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-91 [12634041691]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-40 [12634041640]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-98 [12634041698]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-59 [12634041659]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-00 [12634041600]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-97 [12634041697]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-63 [12634041663]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-69 [12634041669]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-84 [12634041684]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-90 [12634041690]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-94 [12634041694]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-71 [12634041671]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-18 [12634041618]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-61 [12634041661]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-81 [12634041681]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-78 [12634041678]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-79 [12634041679]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-50 [12634041650]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-54 [12634041654]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-09 [12634041609]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-52 [12634041652]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-67 [12634041667]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-12 [12634041612]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-80 [12634041680]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-45 [12634041645]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-96 [12634041696]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-01 [12634041601]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-99 [12634041699]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-74 [12634041674]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-95 [12634041695]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-60 [12634041660]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-57 [12634041657]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-93 [12634041693]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-66 [12634041666]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-85 [12634041685]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

NDC 12634-416-92 [12634041692]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA077293
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-24

Drug Details

Active Ingredients

IngredientStrength
FUROSEMIDE20 mg/1

OpenFDA Data

SPL SET ID:46675cd8-ad7e-40ae-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310429

    • Pharmacological Class

    • Increased Diuresis at Loop of Henle [PE]
    • Loop Diuretic [EPC]
    • Increased Diuresis at Loop of Henle [PE]
    • Loop Diuretic [EPC]

    NDC Crossover Matching brand name "Furosemide" or generic name "Furosemide"

    NDCBrand NameGeneric Name
    0054-3294FurosemideFurosemide
    0054-3298FurosemideFurosemide
    0054-4297FurosemideFurosemide
    0054-4299FurosemideFurosemide
    0054-4301FurosemideFurosemide
    0054-8297FurosemideFurosemide
    0054-8299FurosemideFurosemide
    0054-8301FurosemideFurosemide
    0378-0208Furosemidefurosemide
    0378-0216Furosemidefurosemide
    0378-0232Furosemidefurosemide
    0404-9861FurosemideFurosemide
    0404-9862FUROSEMIDEfurosemide
    0404-9863FurosemideFurosemide
    0404-9864FUROSEMIDEfurosemide
    0409-1639FurosemideFUROSEMIDE
    0409-6102FUROSEMIDEFUROSEMIDE
    68071-1708FurosemideFurosemide
    68071-1809FurosemideFurosemide
    68071-3273FurosemideFurosemide
    68071-3144FurosemideFurosemide
    68071-3194FurosemideFurosemide
    68071-3148FurosemideFurosemide
    68071-4015FurosemideFurosemide
    68071-4022FurosemideFurosemide
    68071-4349FurosemideFurosemide
    68071-4534FurosemideFurosemide
    0409-9631FurosemideFurosemide
    68071-4445FurosemideFurosemide
    68071-4522FurosemideFurosemide
    68094-867FurosemideFurosemide
    68094-756FurosemideFurosemide
    68788-1966FurosemideFurosemide
    68788-6397FurosemideFurosemide
    68788-6784FurosemideFurosemide
    68788-7265FurosemideFurosemide
    68788-6948FurosemideFurosemide
    68788-9226FurosemideFurosemide
    68788-7354FurosemideFurosemide
    68788-9778FurosemideFurosemide
    69315-116FurosemideFurosemide
    69315-118FurosemideFurosemide
    69315-117FurosemideFurosemide
    69677-204FurosemideFurosemide
    70121-1164FurosemideFurosemide
    70121-1076FurosemideFurosemide
    70121-1163FurosemideFurosemide
    70518-0092FurosemideFurosemide
    70518-0584FurosemideFurosemide
    70518-0120FurosemideFurosemide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.